Harraden Circle Investments’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History

Harraden Circle Investments’s Portfolio BLACR Stock Details BLACR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-524,343	Closed	-$58.3K	–	132
2024 Q4	$58.3K	Buy	+524,343	New	+$65.8K	0.05%	84

Harraden Circle Investments's BLACR Position: Q1 2025 in Review

Harraden Circle Investments sold out of Bellevue Life Sciences Acquisition Corp. Rights (BLACR) in Q1 2025, closing a stake of 524,343 shares — an estimated $58.3K sold.

Harraden Circle Investments first reported a position in BLACR in Q4 2024 and held it in 1 quarter. The position peaked at $58.3K in Q4 2024. 0 funds tracked by Wall St. Rank hold BLACR as of Q1 2025.

Harraden Circle Investments reported no remaining Bellevue Life Sciences Acquisition Corp. Rights position as of Q1 2025 after selling out during the quarter.
Harraden Circle Investments sold 524,343 Bellevue Life Sciences Acquisition Corp. Rights shares in Q1 2025, an estimated $58.3K.
Harraden Circle Investments first reported a position in Bellevue Life Sciences Acquisition Corp. Rights in Q4 2024 and held it in 1 quarter.
Harraden Circle Investments's Bellevue Life Sciences Acquisition Corp. Rights position peaked at $58.3K in Q4 2024.
0 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Rights as of Q1 2025.

Based on Harraden Circle Investments's 13F filing for Q1 2025, filed 15 May 2025.